BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 106 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $25,991,000 | -61.2% | 504,980 | -72.2% | 2.59% | -69.7% |
| Q4 2018 | $67,057,000 | -12.9% | 1,813,340 | -11.5% | 8.56% | +10.4% |
| Q3 2018 | $76,960,000 | -5.0% | 2,049,545 | 0.0% | 7.76% | -25.7% |
| Q2 2018 | $80,998,000 | +53.4% | 2,049,545 | 0.0% | 10.44% | +39.6% |
| Q1 2018 | $52,796,000 | -1.0% | 2,049,545 | +3.7% | 7.48% | -34.5% |
| Q4 2017 | $53,335,000 | -27.8% | 1,976,818 | 0.0% | 11.42% | -23.5% |
| Q3 2017 | $73,893,000 | – | 1,976,818 | – | 14.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |